Recurring production/supply shortages of life-sustaining medicines occur. This article examines whether a patient who is prescribed such a medicine ought to have a legal remedy against the medicines supplier if the shortage is found to be negligently (or intentionally) caused. Finding that no such legal remedy exists presently, the article offers a statutory revision that might both safeguard patients against persistent supply interruptions and yet preserve the intellectual property holder's interest in its invention.